共 50 条
- [41] Evaluation of PD-1/PD-L1 and CTLA-4 immune checkpoints and angiogenic activity in ovarian cancer after oncotherad immunotherapy associated to erythropoietin.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17560 - E17560de Souza, Bianca RibeiroOliveira, GabrielaLeme, GiovanaReis, Ianny BrumTossini Cabral, Felippe AugustoBaggio de Paula, Juliane Limada Silva Santos, Daniel HenriqueFelizzola, Claudia RoncaDuran, NelsonFavaro, Wagner Jose
- [42] PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell CarcinomasANIMALS, 2021, 11 (07):Porcellato, IlariaMecocci, SamantaBrachelente, ChiaraCappelli, KatiaArmando, FedericoTognoloni, AlessiaChiaradia, ElisabettaStefanetti, ValentinaMechelli, LucaPepe, MarcoGialletti, RodolfoPasseri, BenedettaGhelardi, AlessandroRazzuoli, Elisabetta
- [43] Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backupsNature Immunology, 2019, 20 : 1425 - 1434Lawrence P. AndrewsHiroshi YanoDario A. A. Vignali
- [44] Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backupsNATURE IMMUNOLOGY, 2019, 20 (11) : 1425 - 1434Andrews, Lawrence P.Yano, HiroshiVignali, Dario A. A.
- [45] PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young WomenLABORATORY INVESTIGATION, 2019, 99Obeidin, FarresPincus, JenniferSiziopikou, K. P.Blanco, Luis
- [46] GENERALIZABILITY OF POTENTIAL BIOMARKERS OF RESPONSE TO CTLA-4 AND PD-1 BLOCKADE THERAPY IN CANCERJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A46 - A47Bortone, DanteVensko, StevenEntwistle, SarahCogdill, AlexandriaMonette, AnneNajjar, YanaSweis, RandyTschernia, NicholasWennerberg, ErikBommareddy, PraveenHaymaker, CaraKhan, UqbaMcGee, HeatherPark, WungkiSater, HousseinSpencer, ChristineAscierto, MariaBarsan, ValentinPopat, VinitaValpione, SaraWells, DannyThorsson, VesteinnZappasodi, RobertaRudqvist, NilsVincent, Benjamin
- [47] Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell CarcinomaJOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)Kahlmeyer, AndreasStoehr, Christine G.Hartmann, ArndtGoebell, Peter J.Wullich, BerndWach, SvenTaubert, HelgeErlmeier, Franziska
- [48] Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeNATURE MEDICINE, 2021, 27 (08) : 1432 - +Andrews, Miles C.Duong, Connie P. M.Gopalakrishnan, VancheswaranIebba, ValerioChen, Wei-ShenDerosa, LisaKhan, Md Abdul WadudCogdill, Alexandria P.White, Michael G.Wong, Matthew C.Ferrere, GladysFluckiger, AurelieRoberti, Maria P.Opolon, PauleAlou, Maryam TidjaniYonekura, SatoruRoh, WhijaeSpencer, Christine N.Curbelo, Irina FernandezVence, LuisReuben, AlexandreJohnson, SarahArora, ReetakshiMorad, GolnazLastrapes, MatthewBaruch, Erez N.Little, LatashaGumbs, CurtisCooper, Zachary A.Prieto, Peter A.Wani, KhalidaLazar, Alexander J.Tetzlaff, Michael T.Hudgens, Courtney W.Callahan, Margaret K.Adamow, MatthewPostow, Michael A.Ariyan, Charlotte E.Gaudreau, Pierre-OlivierNezi, LuigiRaoult, DidierMihalcioiu, CatalinElkrief, AriellePezo, Rossanna C.Haydu, Lauren E.Simon, Julie M.Tawbi, Hussein A.McQuade, JenniferHwu, PatrickHwu, Wen-Jen
- [49] Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) : 31 - 41De Silva, PushpamaliAiello, MarcoGu-Trantien, ChunyanMigliori, EdoardoWillard-Gallo, KarenSolinas, Cinzia
- [50] EXPRESSION OF PD-1 AND CTLA-4 IS INCREASED DURING SYMPTOMATIC PHASE OF ACUTE HEPATITIS AJOURNAL OF HEPATOLOGY, 2013, 58 : S140 - S141Kim, C. W.Cho, H.Kim, H. Y.Lee, S. W.Jang, J. W.Choi, J. Y.Yoon, S. K.Lee, C. D.